These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7800076)

  • 1. [Pulmonary hypertension following use of fenfluramine for obesity].
    Maesen BL; Snijder RJ; Stricker BH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2500-2. PubMed ID: 7800076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of chronic pulmonary hypertension after fenfluramine intake].
    Gaul G; Blazek G; Deutsch E; Heeger H
    Wien Klin Wochenschr; 1982 Nov; 94(22):618-22. PubMed ID: 7164466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension and fenfluramine.
    Pouwels HM; Smeets JL; Cheriex EC; Wouters EF
    Eur Respir J; 1990 May; 3(5):606-7. PubMed ID: 2376256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenfluramine-associated hypertension.
    Mabadeje AF
    West Afr J Pharmacol Drug Res; 1975 Dec; 2(2):145-52. PubMed ID: 1233823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension and fenfluramine.
    Douglas JG; Munro JF; Kitchin AH; Muir AL; Proudfoot AT
    Br Med J (Clin Res Ed); 1981 Oct; 283(6296):881-3. PubMed ID: 6793158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for obesity -- do the benefits outweigh the risks?
    Manson JE; Faich GA
    N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?
    Voelkel NF; Clarke WR; Higenbottam T
    Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009
    [No Abstract]   [Full Text] [Related]  

  • 8. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary pulmonary hypertension and long-term use of appetite suppressants.
    Sztuke-Fournier A
    CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary hypertension, hyperthyroidism, and fenfluramine: a case report and review.
    Leung YY; Tang KS; Tsang CC; Chan CK; Wong KK; Yu AW
    MedGenMed; 2006 Nov; 8(4):29. PubMed ID: 17415311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe pulmonary hypertension complicating a long treatment with dexfenfluramine].
    Ferrari E; Drai E; Jourdan J; Sanchez B; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1994 Feb; 87(2):285-6. PubMed ID: 7802538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexfenfluramine.
    Spollett G
    Lippincotts Prim Care Pract; 1997; 1(3):320-3. PubMed ID: 9238953
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.
    Tellier P
    Ann Med Interne (Paris); 2001 Nov; 152(7):429-36. PubMed ID: 11965083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Fenfluramine-induced hypertension.
    Mabadeje AF
    West Afr J Pharmacol Drug Res; 1974 Dec; 2(1):54P. PubMed ID: 4470636
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 18. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
    Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
    N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombocyte behavior in patients with "primary" pulmonary hypertension. Pathogenesis of aminorex-induced pulmonary hypertension].
    Mlczoch J
    Acta Med Austriaca Suppl; 1980; 19():1-28. PubMed ID: 6939206
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.